193 related articles for article (PubMed ID: 2189623)
1. Quinapril: overview of preclinical data.
Kaplan HR; Taylor DG; Olson SC
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
[TBL] [Abstract][Full Text] [Related]
2. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.
Kaplan HR; Taylor DG; Olson SC; Andrews LK
Angiology; 1989 Apr; 40(4 Pt 2):335-50. PubMed ID: 2539761
[TBL] [Abstract][Full Text] [Related]
3. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
5. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Major TC; Overhiser RW; Taylor DG; Panek RL
J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters.
Benetos A; Albaladejo P; Levy BI; Safar ME
J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
[TBL] [Abstract][Full Text] [Related]
10. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
[TBL] [Abstract][Full Text] [Related]
13. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
[TBL] [Abstract][Full Text] [Related]
14. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
Nakajima T; Yamada T; Setoguchi M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675
[TBL] [Abstract][Full Text] [Related]
15. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
[TBL] [Abstract][Full Text] [Related]
17. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
Vacher E; Fornes P; Domergue V; Richer C; Bruneval P; Giudicelli JF
Am J Hypertens; 1993 Nov; 6(11 Pt 1):951-9. PubMed ID: 8305170
[TBL] [Abstract][Full Text] [Related]
18. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
19. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
20. Overview of quinapril, a new ACE inhibitor.
Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
